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Asthma is associated with frequent use of primary health services and places a burden on the 
United States economy. Identifying key factors associated with increased cost of asthma is an 
essential step to improve practices of asthma management. 
The aim of this study was to identify factors associated with over utilization of primary health 
services and increased cost via claims data and to explore the effectiveness of case management 
program in reducing overall asthma related cost. 
Claims data analysis for Medicaid insured asthma patients in Louisiana was conducted. 
Asthma patients were identified using their ICD-9 and ICD-10 codes, forward variable selection 
was used to identify significant factors in the regression model with total cost as the dependent 
variable, multivariate regression was used to identify patients’ factors associated with frequent 
utilization of primary health services, and finally, a T-test was used to compare the difference in 
cost over time for case managed and non-case managed patients. 
Cost of four claims categories was significant to the total cost variable: primary physician 
visits, pharmacy prescriptions, emergency room visits and urgent care clinics visits. Median 
income and enrollment in case management were significant in predicting number of emergency 
room visits. Patients who had higher income were more likely to utilize urgent care clinics. As a 
side finding, this study built a prediction model for total cost, the linear regression model 
accuracy was compared to neural networks and the proposed threshold point in which neural 
network outperforms the regression model is around 6,000 data points. 
Patients with a history of utilization of certain health services are more likely to need case 
management for better health outcomes and controlled cost. future work is to perform analysis 
on a larger scale and include more patients related factors to identify a more holistic definition 





Healthcare is one of the largest industries in the world. The United States has the highest 
healthcare expenses as compared to other countries and the US Health System ranks last among 
eleven developed countries on measures of access, equity, quality, efficiency, and healthy lives 
(Davis, Stremikis, Squires, & Schoen, 2014). As a share of the Gross Domestic Product (GDP), 
healthcare spending accounted for 17.1% in 2013 (Squires & Anderson, 2015). According to the 
National Health Expenditure (NHE) Data, in 2014, the US healthcare spending increased 5.3 
percent following growth of 2.9 in 2013 to reach $3 trillion, or $9,523 per person. The faster 
growth in 2014 was primarily due to major coverage expansions under Affordable Care Act (ACA), 
particularly, for Medicaid and private health insurance.  
 
 
Figure 1.1. United States Healthcare Spending as a Share of GDP (Source: The Economist 
Intelligence Unit) 
NHE grew 5.8% to $3.2 trillion in 2015 and accounted for 17.8% of GDP. Medicare and 
Medicaid spending grew 4.5% and 9.7% respectively in 2015. Moreover, prescription drug 
spending increased 9% and hospital expenditure grew 5.6% in 2015 (Centers for Medicare & 
Medicaid Services, 2017).  
Healthcare high costs can be attributed to clinical, demographic, geographic, economic 
and other factors. Due to the high spending in healthcare that is continuing to take almost 17% 
of USA GDP over the past years, a healthcare system reform is driven by the motive to change or 
develop policies to enhance the healthcare delivery system and control cost. The ACA initiated 
the Hospital Readmissions Reduction Program (HRRP), which requires CMS to reduce payments 
to Inpatient Prospective Payment System (IPPS) hospitals with excess readmissions for applicable 
chronic conditions with high readmission rates such as heart failure, pneumonia and chronic 
obstructive pulmonary disease (COPD) (Centers for Medicare & Medicaid Services, 2016).  
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Asthma is a leading cause of hospitalization among children, and about 15-50% of 
pediatric patients are readmitted after an index admission (Chung, Hathaway, & Lew, 2015). 
Asthma is one of America’s most common and costly chronic diseases. According to the 
Centers for Disease Control (CDC) about 25 million Americans have asthma. Asthma places 
significant health and economic burden on patients, their families and society (Zein et al., 2016). 
It is the leading chronic disease in children and it’s the top reason for missed school days (Centers 
for Disease Control and Prevention, 2012). Asthma is associated with the utilization of health 
services and it causes almost 2 million emergency room visits each year (United States 
Environmental Protection Agency, 2013). 
In 2017, the U.S. Center for Disease Control and Prevention reported that more than 14 
million doctor visits and 439,000 hospital stays each year, it also reported that in 2015, 3,615 
people died from asthma. Many of these deaths and services utilization are considered avoidable 
with proper treatment and care (Centers for Disease Control and Prevention, 2017). 
The annual total cost of asthma is $56 billion (Centers for Disease Control and Prevention, 
2012). Total cost includes direct cost of health services utilization (prescription medications 
account for more than 50% of direct cost of asthma) and indirect cost of missed school or work 
days and lost pay from illness or death (Barnett & Nurmagambetov, 2011). Several medical 
interventions have been used to control healthcare cost for asthma patients. Case management 
is one type of intervention that has proven to be successful, case managers role is to help asthma 
patients identify and address their challenge with asthma management. A study found that a 
follow-up call by case managers to caregivers of children with asthma have increased visits to 
asthma clinics by almost one-third and improved patient care practices(Fisher-Owens, 
Boddupalli, & Thyne, 2011). Also, another study reported a 33% drop in hospitalization rates and 
a 52% drop in length of hospital stay among adults with asthma after introducing a 
multidisciplinary team for case management (Burke et al., 2016).  
In order to address the main issue of potentially avoidable high utilization of health 
services, better manage chronic diseases to improve the dynamics of the US healthcare systems 
(e.g. improve healthcare outcome and reduce cost) and to move up in the world rankings, there 
is a need to identify factors associated with high-risk patients and to invest in care management 
programs targeted at the right population. This study aimed to identify key factors of high-risk 
asthma patients to be enrolled in case management programs based on data analysis outcomes.  
This study analyzed patients’ claims data provided by a Louisiana based insurance company to 
identify key factors (clinical and non-clinical) that contribute to increased cost and frequent use 
of healthcare resources. The study population was asthma patients in Louisiana who are 
Medicaid insured and who have a primary or secondary asthma diagnosis. Moreover, this study 




1.1 Study motivation 
Although there is no cure for asthma, it can still be managed with proper treatment and 
prevention care. Proper asthma management particularly for high-risk patients can aid in 
improving the quality of life for patients with asthma and in controlling the cost associated with 
health resources utilization. High risk patients are those patients that are at risk of not managing 
their condition, not adhering to their medication and not following doctors’ orders, which will 
result in adverse health outcomes. A study of a random sample of 1678 adults in Southeast 
Virginia found that those with asthma were more likely to report poor physical health and utilize 
more treatment services such as hospitalization and emergency department visits as compared 
to those without asthma (Behr, Diaz, & Akpinar-Elci, 2016). Consequently, asthma patients are 
characterized as frequent users of primary health services and represent a targeted population 
in care management programs. A successful investment in case management programs targeted 
at the right population of asthma patients may result in better practice of case management 
programs, improved health outcomes, less demand on health services and decreased cost.  
1.2 Research objectives 
The main goal of this study was to identify key factors associated with frequent use of 
primary health services and increased cost via asthma patients’ claims data. Moreover, this study 
explored the effectiveness of case management programs in reducing utilization and cost, and, 
finally, this study built two prediction models for total cost and compared the accuracy of 
prediction between the two models: linear regression model and Neural Networks and proposed 
the threshold point in which the Neural Networks model outperforms the linear regression in the 




 Literature Review 
2.1 Asthma definition and statistics  
The National Institutes of Health (NIH) defines asthma as a chronic lung disease that 
inflames and narrows the airways. It restricts the passage of air into the lungs and leads to 
episodes of wheezing, coughing, chest tightness, and shortness of breath. According to the World 
Health Organization (WHO), asthma is the most common disease among children and currently, 
an estimated of 235 million people suffer from asthma world-wide. Asthmatic patients 
experience episodic flare-ups (exacerbations) that might be acute or subacute.  Severe asthmatic 
episodes can close off airways completely and, in some cases, may be life-threatening. When a 
patient experiences increased symptoms and deterioration in lung functions, an intense 
treatment will be required (Global Initiative for Asthma - GINA, 2017). Patients can get asthma 
attacks if they are exposed to “asthma triggers” which may result in costly utilization of 
healthcare services such as emergency department visits and hospitalization.  According to the 
Centers for Disease Control and Prevention, the most common triggers that may cause asthma 
attacks are: tobacco smoke, dust mites, outdoor air pollution, pets, smoke from burning wood or 
grass, mold and other infections linked to flu or cold. In 2015, 46.9% of asthma patients reported 
having one or more asthma attacks (Centers for Disease Control and Prevention, 2017).  
Asthma prevalence has been receiving a lot of attention by researchers. According to the 
Centers for Disease Control and Prevention summary health statistics, 7.6% of adults in the 
United States currently have asthma compared to 8.4% of children(Centers for Disease Control 
and Prevention, 2015). Asthma prevalence refers to percentage of people who have ever been 
diagnosed with asthma and still have asthma and it’s been increasing, the percentage of people 
diagnosed with asthma in the United states increased from 7.3% in 2001 to 8.4% in 2010. 
Moreover, an estimated 25.7 million people had asthma: 18.7 million adults aged 18 and over, 
and 7.0 million children aged 0–17 years as reported in 2010 (Akinbami et al., 2012).  
In 2008, an estimated 264,428 adults and 97,069 children in Louisiana had asthma 
(Centers for Disease Control and Prevention, 2008). Asthma prevalence rate for Medicaid 
recipients in 2008 was 2.2% and the Medicaid population aged 10 years or less had the highest 
number of enrollees in 2007 and 2008 with a total number of claims 225,384 in both 2007 and 
2008 (Asthma Management and Prevention Program & Louisiana Department of Health & 
Hospitals, 2010). 
In 2011, The Louisiana Department of Health and Hospitals issued a Louisiana Asthma 
Burden Fact sheet that reported asthma prevalence based on demographics and economic 
characteristics. It was found that females are more likely to have the disease than males, and 
blacks are more likely to have asthma as compared to whites. Adults with an income of less than 
$15,000 and those with education less than high school have significantly higher rates of asthma 
than those in higher income and education levels (Louisiana Department of Health & Hospitals, 
2011).   
5 
 
An analysis of the Louisiana Hospital Inpatient Discharge Database found a total of 21,398 
adult inpatient hospitalizations during the period 2006 – 2011, with asthma as the primary 
discharge diagnosis (Lewis, Lackovic, & Soileau, 2015). During 2002-2008, children under five had 
the highest hospital discharge rates of all age groups, and the rate for asthma hospitalizations 
decreased during adolescent years, but increased around age 30 (Asthma Management and 
Prevention Program: Louisiana Department of Health and Hospitals, 2008). About 23 percent of 
high school students have missed at least one or more school days due to asthma (Louisiana 
Department of Health & Hospitals, 2011). It is thus obvious that asthma places a burden of the 
economy and society in Louisiana. 
2.2 Health resources utilization statistics and cost 
Health services utilization is defined as the quantity of health services used by patients. 
Health services/resources include but are not limited to: hospitalizations, readmissions, 
emergency department visits, urgent care clinics visits, outpatient office visits and prescription 
drugs. Hospital readmission is defined by the Centers for Medicare and Medicaid Services (CMS), 
as a patient admission to a hospital within 30 days of discharge from the same or another hospital 
(Centers for Medicare & Medicaid Services, 2016). Nearly twenty percent of Medicare patients 
discharged from hospitals are readmitted within 30 days (Jencks, Williams, & Coleman, 2009a). 
The Medicare Payment Advisory Commission (MedPAC) had estimated that 12% of readmissions 
are potentially avoidable with improved discharge process in terms of appropriateness of 
discharge timing and site (home or other care facilities). Preventable hospital readmissions 
contribute to a big part of avoidable medical spending.  According to the data from the Center of 
Health Information and Analysis (CHIA) the estimated annual cost of hospital readmission for 
Medicare patients is $26 billion yearly with approximately $17 billion considered preventable 
with careful planning and communication among patients’ providers, caregivers, community 
social services and patients’ themselves (Reardon, 2015). Consequently, one of the key aspects 
of healthcare reform in the US is the attempt to lower the number of avoidable hospitalizations 
and other health services utilization as a way to improve quality of care and reduce cost.  
As mentioned before, the annual cost for asthma is about $56 billion (United States 
Environmental Protection Agency, 2013). Direct costs make up almost $50.1 billion while indirect 
costs make up $5.9 billion (Barnett & Nurmagambetov, 2011). Direct costs include inpatient care, 
emergency department visits, ICU admissions, urgent care clinics visits, physician services, 
nursing services, ambulance use, drugs, devices and outpatient diagnostic tests, while the 
indirect costs include lost pay from sickness, lost work output from missed school and work days 
and asthma-related death (Krahn, Berka, Langlois, & Detsky, 1996). 
In the US, asthma is the single most common condition in children and one of the leading 
causes of hospital admission and readmissions, In 2010, asthma accounted for 3,404 deaths and 
439,400 hospitalizations (Centers for Disease Control and Prevention, 2013). In 2013, 6.5% of 
visits to office-based physician indicated asthma on the medical record, and a total of 1.6 million 
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visits to emergency departments with asthma as the primary diagnosis (Centers for Disease 
Control and Prevention, 2013b). According to the National Hospital Ambulatory Medical Care 
Survey in 2010, the number of hospital outpatient department visits was 1.3 million for asthmatic 
patients (Centers for Disease Control and Prevention, 2010).  
Previous studies had investigated the healthcare costs and resource utilization associated 
with asthmatic patients and found that the average cost per asthma-related hospital stay for 
children remained relatively stable at about $3,600 from 2000 to 2010, whereas the average cost 
per asthma-related hospital stay for adults increased from $5,200 to $6,600 (Barrett, Wier, & 
Washington, 2014). A nationwide, cross-sectional study using data from the Medical Expenditure 
Panel survey found that the average charge for an asthma-related outpatient ED visit from 2006 
to 2008 was $1,502 (Wang, Srebotnjak, Brownell, & Hsia, 2014). 
Since 2009, the cost of inhaled asthma medicines have increase by an average of 50 
percent (Consumer Reports, 2013). In 2014, Medicaid spent about $67 per member each year on 
asthma medicine, which is the third highest of any category. However, by the end of 2014, the 
price of asthma medications per member each year has dropped by almost 15 percent mostly 
because the cost per unit has dropped, this in turn has caused asthma to drop to the seventh 
most costly illness (The Express Scripts Lab, 2015). Moreover, it’s worth mentioning that an 
estimated 54.9 percent of adults and 78.3 percent of children are not committed to using the 
medications (Consumer Reports, 2013).  
2.3 Factors associated with higher health resources utilization 
There are a variety of clinical and non-clinical factors that can influence the level of 
patients utilization of primary health services. Clinical factors include poor-quality care, 
insufficient care coordination between providers (physicians, nurses and pharmacists), patients 
illness severity, and any adverse outcomes. It’s also worth mentioning that increased cost and 
utilization can be largely driven by patients circumstances and behavior, such as lack of social 
support and patients adherence to treatment, which are out of the healthcare providers control. 
Therefore, previous studies explored non-clinical factors (i.e. demographic and socio-economic) 
influence on readmission rates and other primary care services. 
The diagnosis of asthma severity level has been investigated in the past as a potential 
reason for higher health resources utilization and increased cost. According to GINA (Global 
Initiative for Asthma - GINA, 2017), asthma severity is assessed retrospectively from the level of 
treatment required to control symptoms and exacerbations.  
 Mild asthma is asthma that is well controlled with step 1 or step 2 treatment (as-
needed reliever medication alone, or with low intensity controller treatment such 
as low dose ICS1, leukotriene receptor antagonists or chromones).  
                                                     
1 ICS: long-term control medications, used for prevention/control of asthma, not treatment of acute exacerbations 
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 Moderate asthma is the asthma that is well controlled with low dose ICS/LABA2.  
 Severe asthma is the asthma that requires a high-dose ICS/LABA, to prevent it 
from becoming uncontrolled, or asthma that remains uncontrolled despite this 
treatment.    
It’s important to distinguish between asthma severity and asthma control. The GINA 
guidelines define asthma control as “the extent to which the effect of asthma can be seen in the 
patient or have been reduced or removed by treatment”. Asthma control has two aspects: 
symptom control and risk factors for poor future outcomes. Poor symptom control is a burden 
to patient and a risk factor for flare-ups. A risk factor is a factor that increases the patients’ future 
risk of exacerbations, loss of lung function, or medication side effect. (Global Initiative for Asthma 
- GINA, 2017).  
2.4 Intervention programs    
A medical intervention in general is defined as any medical procedure or application that 
is intended to relieve an illness or injury. For asthma patients, an intervention aims to help 
patients better control their disease and prevent asthma exacerbations, which can reduce the 
economic burden of asthma and improve patients qualify of life. Although the exact cause of 
asthma is unknown and it cannot be cured, it still can be controlled with self-management 
education, appropriate medical care, and avoiding exposure to environmental triggers that might 
lead to asthmatic episodes.  Uncontrolled asthma can be due to a number of factors with poor 
knowledge and lack of education about the subject being two of them. Several studies reported 
that about half of asthma patients don’t use the inhaler correctly (Al-Zahrani et al., 
2015)(Consumer Reports, 2013). Thus, sufficient education of asthma control can aid in 
improving patients’ health outcomes and reduce the potentially avoidable ED visits and 
hospitalizations with better care. 
2.4.1 Home-based intervention  
“The Community Preventive Services Task Force (CPSTF) recommends the use of home-
based multi-trigger, multicomponent interventions with an environmental focus for children and 
adolescents with asthma to improve overall quality of life and productivity, specifically: 
improving asthma symptoms and reducing the number of school days missed due to asthma. 
Interventions involve home visits by trained personnel and aim to reduce exposure to multiple 
indoor asthma triggers (allergens and irritants) through 2 or more activities. Activities may 
include: assessment of the home environment; changing the indoor home environment to 
reduce exposure to asthma triggers; or education about the home environment. Most programs 
also include non-environmental activities such as training to improve self-management, 
                                                     
2 ICS/LABA combination in a single inhaler represent safe, effective and convenient treatment options for the 
management of patients with asthma and COPD 
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education, social services and support, or coordinated care” (The Community Guide & Centers 
for Disease Control and Prevention, 2014).   
A systematic review of 20 studies on home-based interventions with environmental focus 
to reduce asthma-related outcomes reported reduced asthma symptom-days by 0.8 days per 2 
weeks, reduced missed school days by about 12 days per year and reduced asthma acute care 
visits by 0.57 visits per year (Crocker et al., 2011). 
2.4.2 Asthma self-Management education 
Self-management education is one of the strategies that the CDC’s National Asthma 
Control Program (NACP) suggest to implement to educate patients with asthma on how to 
engage in behaviors and practices that help them gain optimal control of their disease. Self-
management is usually guided by a healthcare professional and it includes asthma education, 
self-monitoring of symptoms and lung function as well as adjusting treatment according to the 
action plan provided by a healthcare provider (Van der Meer et al., 2011).  An analysis of a US 
claim database found that 32% of asthma patients who stepped down their medication had an 
asthma exacerbation in the two years following the step-down event (Rank et al., 2015). It was 
found that families who received an individualized asthma education during patient’s 
hospitalization by trained volunteers had better asthma management behaviors compared to 
patients who received the standard medical management (Rice et al., 2015). A study investigated 
the effectiveness of different educational programs in improving asthma control and it was found 
that individual verbal instructions and integrated asthma classes showed greater improvement 
in QOL questionnaire and asthma control compared to written information in an asthma booklet 
(Urek et al., 2005) 
2.4.3 Multidisciplinary interventions 
In their study, Dinelli & Higgins reported that a combined intervention that includes 
patient education, a coordinated self-monitoring plan and patient follow-up was associated with 
improved care and cost-saving, particularly in reducing the number of clinic visits, the number of 
ordered chest radiographs and asthma relief medications (Dinelli & Higgins, 2002). 
Another study found that a multidisciplinary case management strategy that consisted of 
a consultant, specialist nurse, physiotherapist and psychologist was effective in reducing 
hospitalization rates for patients with persistent asthma (Burke et al., 2016). 
2.4.4 Disease and case management 
Disease management (DM) is a coordinated healthcare system that educates patients 
with chronic diseases on how to better manage their disease and prevent complications. The goal 
of DM is to identify persons at risk for chronic conditions, to promote self-management by 
patients or their caregivers, and to help achieve the best clinical outcomes (Schrijvers, 2009). 
Systematic review and meta-analyses found considerable evidence in the effectiveness and 
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efficiency of DM programs in improving the adherence to guidelines, health outcomes and quality 
of life among patients with chronic illnesses (Hisashige, 2013). 
Asthma is one of the chronic conditions that have been the focus of DM programs. A 
recent study evaluated the effectiveness of disease management programs for adults with 
asthma, patients who were enrolled in chronic disease management program reported 
improvements in asthma-specific quality of life, severity scores, and lung function tests compared 
to usual care (Peytremann-Bridevaux, Arditi, Gex, Bridevaux, & Burnand, 2015).  Another study 
have reported an accumulation of circumstantial evidence that DM programs targeted at asthma 
patients have reduced the utilization of health resources and have improved the aspects of self-
management and organization of care after the implementation of the program (Steuten, 
Lemmens, & Vrijhoef, 2007). 
According to Case Management (CM) Society of America, “case management is a 
collaborative process of assessment, planning, facilitation, care coordination, evaluation, and 
advocacy for options and services to meet an individual’s and family’s comprehensive health 
needs through communication and available resources to promote quality cost-effective 
outcomes”. 
Case management is distinguished from disease management in that it targets high-risk 
patients who due to diverse combinations of health, social and functional problems, are likely to 
need hospitalization. Disease management targets patients who have one major diagnosis and 
who, because of their major diagnosis, have a relatively standard set of needs. Also, Case 
management is often episodic, the interventions are needed over a specific period of time or 
until certain goals are met, or a patient transitioned from one level of care to another. Disease 
management tend to be long term and goes beyond the short-term nature of a health encounter 
(Ahmed, 2016). 
State Medicaid care management programs considers a process for enrollment in the 
programs. First, States must select the eligible population that the program will target, then 
determine how they will identify potential members and finally decide the enrollment strategy 
based on the program. According to Exhibit 3.1. Care management population selection and 
enrollment process issued by the Agency for Healthcare Research and Quality, the Medicaid 
disease and care management programs select eligible population among specific disease, high-
risk members and population-based approach. Care management programs can target specific 
chronic conditions or focus on high-risk and high-cost beneficiaries. These programs can also 
follow a "population-based" approach by including their entire fee-for-service (FFS) and primary 
care case management (PCCM) population or Temporary Assistance for Needy Families (TANF) 
and Supplemental Security Income (SSI) populations within FFS and PCCM and provide the 
interventions appropriate for the member's risk level or disease. After selecting the eligible 
population, these programs must identify and stratify members by utilizing several tools such as 
claims data, risk stratification, health assessment tools and predictive modeling. Finally, the 
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technique in which the program chooses to enroll and engage members varies based on program 
design (Agency for Healthcare Research and Quality, Rockville, MD, 2014). 
2.4.5 Common success factors for case management from literature 
A previous study identified asthma interventions from previous literature that had 
positive asthma outcomes, and identified the following characteristics to be associated with a 
successful asthma program “1. were community based, (2) engaged the participation of 
community-based organizations, (3) provided program components in a clinical setting, (4) 
provided asthma training to health-care providers, (5) collaborated with other organizations and 
institutions and with government agencies, (6) designed a program for a specific racial/ethnic 
group, (7) tailored content or delivery based on individual health or educational needs, and (8) 
conducted environmental assessments and tailored interventions based on these assessments” 
(Clark, Lachance, Milanovich, Stoll, & Awad, 2009a).  
Another study that reviewed asthma programs targeted at children with asthma found 
that the common factors for success involve case managers spending time contacting and 
patiently and persistently working with the family, which contributes to building a trusting 
relationship, consequently, the positive outcomes benefit all parties involved (Schulte, Musolf, 
Meurer, Cohn, & Kelly, 2004) 
Developing and implementing an intervention program targeted at asthma patients with 
the previously mentioned characteristics will be more likely to yield positive outcomes. 
2.5 High-risk patients definition from previous studies 
CMS contracted the National Committee for Quality Assurance (NCQA) to develop a tool 
to evaluate quality and performance on important dimensions of care and service, this tool is 
referred to as The Health Plan Employer Data and Information Set (HEDIS) (Centers for Medicare 
and Medicaid Services, 2017) .  
HEDIS developed a definition of patients with asthma who are at risk of adverse outcomes 
by analyzing 12-months of utilization data. Patients who had at least one or more of the following 
types of utilization were defined as high-risk:  
1.  At least one hospitalization in the past year with an asthma diagnosis and had at least 
one asthma prescription during that year  
2. At least one emergency department or urgent care visit in the past year with an 
asthma diagnosis and had at least one asthma prescription during that year  
3. At least two office visits in the past year with an asthma diagnosis and had at least 
one asthma prescription during that year  
4. At least one visit in the past year with an asthma diagnosis and another in the past 18 
months and had at least one asthma prescription 
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5. At least four prescriptions for asthma medication in the past year (Bennett, Lozano, 
Richardson, McCauley, & Katon, 2008) 
The Global Initiative for Asthma (GINA) guidelines for identifying risk factors for poor 
asthma outcomes states that having one or more of the following risk factors increases the risk 
of exacerbations even if asthma is well controlled: 
 Uncontrolled asthma symptoms  
 ICS not prescribed, poor ICS adherence; incorrect inhaler technique 
 High SABA3 use  
 Low FEV 
 Major psychological or socioeconomic problems 
 Exposures: smoking, allergen exposure 
 Comorbidities: obesity, rhinosinusitis; confirmed food allergy 
 Sputum or blood eosinophilia; elevated FENO in allergic adults 
 Pregnancy 
 Ever been intubated or in intensive care for asthma 
 Having 1 or more severe exacerbations in the last 12 months 
Previous studies have identified high-risk patients who will potentially over-utilize the 
primary health services in terms of their demographics, socio-economic status, disease severity 
and level of utilization of primary health services. There were multiple data sources including 
hospital databases, claims data, interviews and questionnaires which we will explore in the next 
section. 
2.6 Previous studies data sources 
2.6.1 Hospital databases  
A study in Thailand that used hospital electronic databases to analyze asthmatic patients 
data, reported that patients diagnosed with high severe asthma had higher utilization of 
healthcare resources compared to patients who had mild/moderate severe asthma 
(Dilokthornsakul, Lee, Dhippayom, Jeanpeerapong, & Chaiyakunapruk, 2016).  
Nath & Hsia utilized data from the National Hospital Ambulatory Medical Care Survey and 
found that Children who were younger, male, belonged to racial or ethnic minorities, and insured 
with Medicaid/CHIP had higher ER visits (Nath & Hsia, 2015). 
In their study that utilized Public health Service Hospitals database in Spain, Gonzalez-
Barcala et al. found that female patients over 60 years of age had higher hospitalization rates due 
to asthma and longer hospital stays (Gonzalez-Barcala et al., 2011). 
                                                     
3 SABA: Short-Acting Beta Agonists are rescue medications that are fast acting and temporarily relief symptoms  
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2.6.2 Government agency database 
Another study analyzed data collected by the Agency of Healthcare Research and Quality 
through the Medical Expenditure Panel Survey of children aged from 0-11 years during 2001-
2006 period. The study found that exposure to asthma triggers such as secondhand smoke was 
associated with higher utilization of hospitals and emergency departments among children with 
asthma as compared to children without asthma (Jin, Seiber, & Ferketich, 2013).  
2.6.3  Interview and questionnaires  
In their study, Eisner et. al found that non-white race, lower income, and greater asthma 
severity level were identified as risk factors for subsequent hospitalization among adults with 
asthma (Eisner, Katz, Yelin, Shiboski, & Blanc, 2001).  
A previous study that conducted interviews with minority inner city asthma patients and 
collected data on their ED visits and hospital admissions, the study reported that patients with 
no established primary care provider, spoke mostly Spanish and reported allergy to cockroaches 
were associated with higher resource utilization and worse quality of life (Wisnivesky, Leventhal, 
& Halm, 2005). 
An administered a questionnaire in which a random, stratified sample of 1678 adult were 
asked to self-report their primary care visits, emergency department visit, admission to a hospital 
found that those diagnosed with asthma were more likely to frequently utilize primary care 
services for matters associated with management of condition, treatment or hospitalization after 
an acute and episodic attack (Behr et al., 2016).  
2.6.4 Insurance claims data 
In Germany, an analysis of claims data found that patients with a primary or secondary 
asthma diagnosis had significantly higher inpatient, outpatient visits as well as a higher number 
of pharmaceuticals prescriptions compared to patients without asthma. Moreover, the study also 
showed that patients with persistent asthma had higher asthma-related cost compared to 
patients with intermittent asthma (Jacob et al., 2016). 
2.7 Research gap 
Previous studies reported asthma prevalence (Lewis et al., 2015), (Akinbami et al., 2012),  
statistics and cost of utilizing primary health services (Reardon, 2015), (Jencks, Williams, & 
Coleman, 2009b), (Krahn et al., 1996), (Wang et al., 2014).  Other studies looked at different types 
of intervention programs targeted at asthma patients and reported the outcomes in terms of 
better care and lower cost (Crocker et al., 2011), (Van der Meer et al., 2011), (Urek et al., 2005), 
(Burke et al., 2016) and identified common success factors for asthma programs with positive 
outcomes (Clark, Lachance, Milanovich, Stoll, & Awad, 2009b), (Schulte et al., 2004). 
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Moreover, the literature had previous work that defined high-risk patients that are more 
likely to overutilize primary health services while utilizing multiple database sources such as: 
government (Jin et al., 2013) , hospital databases (Dilokthornsakul et al., 2016), (Nath & Hsia, 
2015), interview and surveys (Eisner et al., 2001), (Wisnivesky et al., 2005), (Behr et al., 2016), 
and insurance claims (Jacob et al., 2016). 
There is a need for a comprehensive study that utilizes patients’ claims data and propose 
a holistic definition of high-risk patients based on their demographics, history of utilization of 
health care services and cost. This study utilized Medicaid patients’ claims data in from an 
insurance agency in Louisiana to identify factors associated with high-risk asthma patients that 
could benefit from a case management program, moreover, this study also compared the 
accuracy of prediction between a linear regression model and neural networks, and presented 
the number of data points needed to train neural network to outperform regression.  
In the health insurance agency where this study took place, all patients with an asthma 
diagnosis or any other chronic illness are considered eligible for case management. However, a 
common observation among patients in the eligible population is that they have low enrollment 
rate in case management (for asthma, enrollment rate is 14% among all members). That is, case 
managers would reach out to patients and offer them the service, and the patients have the 
choice to accept or decline the enrollment in case management. This project analyzed claims data 
to identify, if any, factors are associated with frequent use of health services and increased cost 
among Medicaid asthmatic patients. The higher risk patients can constitute a population that 
might require a particular approach to improve the chances of a patient accepting to be enrolled 




 Research Methodology 
3.1 Study objective  
The primary objective of this study was to identify asthma patients’ key factors associated 
with frequent use of primary health services and increased cost via claims data. Moreover, this 
work explored the effectiveness of case management program in reducing total asthma related 
cost. 
In addition to the primary objective, this study compared the accuracy of two models 
predicting patients’ total cost: linear regression model vs neural networks (NN), and presented a 
heuristic case study for finding the optimal number of data points needed to train the neural 
network to outperform linear regression model in terms of accuracy of prediction.  
3.2 Study setting 
The data source in this study was a healthcare insurance provider based in Baton Rouge, 
Louisiana. The company provides Medicaid or LaChip for qualified members through state’s 
Healthy Louisiana Program and links Medicaid insured members to primary care providers, 
pharmacies and case managers. 
3.3 Ethical consideration 
Institutional Review Board at Louisiana State University reviewed and approved this 
study. The researcher received HIPPA training at the healthcare insurance provider site prior to 
the beginning of the study. Patients’ information was de-identified by the health insurance 
company’s data analytics team according to HIPPA and company policy guidelines before sharing 
the data with the researcher. A generic unique ID was created for each member to link patient 
information across claims files anonymously to protect patients’ information. 
3.4 Study population inclusion and exclusion criteria 
The study population was Medicaid insured patients of all ages who have a primary or 
secondary asthma diagnosis and have had a record of Medicaid Insurance during the study period 
January 1st, 2015 to November 30th, 2017. Members with asthma were identified by using 
International Classification of Diseases. The ninth revision codes (ICD-9Dx) with 493.XXX asthma 
codes and the tenth revision codes (ICD-10Dx) with J45.XXX as asthma codes. Drug NDC4 number 
was used to identify asthma medications. Patients were eligible to be included in the study if they 
have the following criteria: 
 Patients who had a record of Medicaid insurance during the study period  
                                                     
4 National Drug Code: A unique 10-digit, 3-segment number. It is a universal product identifier for human drugs in 
the United States 
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 Patients with primary or secondary diagnosis of asthma 
 Patients who had at least one primary care claim (physician office visit) during the study 
period with asthma as the primary service diagnosis  
Patients who were deceased during the study period, patients who had no primary care claim 
due to asthma during the study period, patients who are older than 75 and patients who had 
missing or invalid information were excluded from the study. Based on the inclusion and 
exclusion criteria 12,029 patients were in the study and 127,762 patients were excluded from the 
study. Patients who were older than 75 years of age were excluded from the study to comply 
with HIPPA regulations to reduce the probability of identifying the subject. 
3.5 Data collection 
Figure 3.1 displays the process of data collection process in terms of data categories 
extracted. Data was extracted from MicroStrategy database, each data category was combined 
in separate excel sheets, patients’ information were linked across data categories using patients’ 
ID. To protect patients’ information, patients ID were de-identified into unique generic unique ID 





Figure 3.1. Data collection process 
The details of the data categories collected from each claim source are displayed in Figure 
3.2. Member data includes age, gender, race, zip code was used to find median income and 
utilized as a socio-economic indicator and patient enrollment CM (Yes/No) and the date of 
enrollment in CM. Hospital & ICU admissions claims data included admission diagnosis, admission 
date, charge data, length of hospital stay, and billed amount. Billed amount refers to the total 
amount that was billed for the cost not just the amount paid by insurance provider. Paid Amisys 
amount is the amount covered by the insurance provider. Pharmacy data included drug 
description, fill date, drug NDC number, billed amount and paid Amisys amount. Emergency 
Department, Urgent Clinic and Primary care visits data included claim’s primary Diagnosis Service 




Figure 3.2. Collected Data: Linked by generic unique ID 
Data was cleaned and filtered for the study population based on the inclusion criteria. 
Admission Diagnosis was used to filter asthma related claims for hospital and ICU admissions 
claims. Primary Diagnosis Service was used to filter asthma related claims in Emergency 
Department, Urgent Care Clinics and Primary care claims.  
For pharmacy files, asthma medications NDC codes were used to identify asthma 
medications claims.  Patients’ claims with a primary service diagnosis other than asthma was not 
included in this study. 
A simple R-based script was written to clean the dataset from incomplete, false, inaccurate 
and missing information. Patients with missing demographic information, or socio-economic 
indicators (zip code) were removed from the dataset. Furthermore, patients with extreme billed 
amount values corresponding to a single claim were removed from the dataset. Patients who had 
zero billed amount corresponding to a claim were also removed. The dataset then was 
conformed to standard notations, features and numeric value presentations.  
3.6 Study population descriptive statistics 
The sample consists of 9,977 asthma patients from all ages including infants and adults (0 
to 73 years). The sample has 4,651 females and 5,326 males. A total of 1,609 patients are enrolled 
in case management, which translates to approximately 16% enrollment rate. 
Table 3.1 displays the breakdown of the study population by age groups; Note that the 
majority of the population is aged 18 and under. 
Table 3.1. Population age groups breakdown 











































































The PROC MEANS by SAS was used to provide descriptive statistics for total cost, age, and 
median income.  
As shown in Table 3.2 the mean of the total cost for the study population is $240 with a 
minimum of $3 and a maximum close to a $1,000. The standard deviation indicates that there is 
no large dispersion of data around the mean, however, by looking at the maximum value, we 
expect to find outliers in the data. 
Table 3.2. Descriptive Statistics for Total Cost 
Analysis Variable: Total_Cost  
N Mean Std Dev Minimum Maximum 
9977 240.4 221.9 3.0 999.8 
 
Table 3.3 presents the descriptive statistics for variable age; the mean is 13 years and the 
standard deviation equals 12.8, which is consistent with what we mentioned earlier about the 
majority of the study population being aged 18 and under. Moreover, the maximum is 73, 
technicality introduced to comply with HIPPA regulations. 
Table 3.3. Descriptive Statistics for Age 
Analysis Variable: Age 
N Mean Std Dev Minimum Maximum 
9977 13.1 12.8 0 73 
 
 The median income was collected by utilizing the patients’ zip codes. Table 3.4 displays 
the descriptive statistics for median income. The mean income is about $42,000 and the standard 
deviation is $6,966. 
Table 3.4. Descriptive Statistics for Income 
Analysis Variable: Income 
N Mean Std Dev Minimum Maximum 
9977 42082.0 6966.2 24038.0 109257.0 
 
Since there is a low enrollment rate in CM, we also added the descriptive statistics of 
patients’ demographics and income for those patients who chose to be enrolled in CM.  
Table 3.5 displays the count for each gender for patients in enrolled in CM. it shows an 
approximately equal ratio between male and female patients. 
Table 3.5. Gender count for patients enrolled in CM 
Male CM patients count Female CM patients count Total 
823 786 1609 
19 
 
Table 3.6Table 3.5 displays the descriptive statistics for age variable. The mean age for patients 
who are case managed is 17 with a low standard deviation of 0.40; this indicates that the 
majority of patients enrolled in CM are younger patients. 
Table 3.6. Descriptive statistics for Age for patients enrolled in CM 
Analysis Variable: Age for CM Patients 
N Mean Std Dev Minimum Maximum 
1609 17 0.40 0 66 
 
Table 3.7 presents the descriptive statistics for income variable. The mean income for enrolled 
patients is about $41,750 and the standard deviation is 7696.  
Table 3.7. Descriptive statistics for Income for patients enrolled in CM 
Analysis Variable: Income for CM Patients 
N Mean Std Dev Minimum Maximum 











4.1 Difference in cost between patients who are case managed vs non-case managed 
The SAS statistical software was used to analyze the difference in total cost between 
patients who are case managed vs. patients that are not case managed. In order to utilize a T-
test comparison, we started by checking the appropriate conditions, using a standard pre-test 
analysis. By design we can guarantee independence of samples between and within the two 
groups. In the absence of a true sigma for standard error in the variable Total Cost the pooled 
sigma is assumed to be a reliable estimate.  
First of all, we tested the Total Cost’s normality assumption. In other words, we performed 
a goodness of fit test with the following hypothesis: 
H0: “Total Cost” follows a normal distribution 
H1: “Total Cost” doesn’t follow a normal distribution 
As shown Table 4.1, the Goodness of fit tests all have p-value smaller than 0.05, therefore, we 
reject the null hypothesis that the data is normally distributed. Moreover, as displayed in Figure 
4.1, the histogram shows that the distribution is skewed to the right. 
Table 4.1. Normality tests for Total Cost variable 
Goodness-of-Fit Tests for Normal Distribution 
Test Statistic p-Value 
Kolmogorov-Smirnov D 0.174 Pr > D <0.010 
Cramer-von Mises W-Sq 109.1 Pr > W-Sq <0.005 
Anderson-Darling A-Sq 616.6 Pr > A-Sq <0.005 
 
Second, we performed a test for homogeneity of variance using Levene’s test for total 
cost calculated for gender and CM as they are the only two variables that can generate 
categories, and the following hypothesis was tested: 
H0:  All variances are equal  
H1: All variances are not equal 
As shown in Table 4.2, the p-value is low, so we reject the null hypothesis, which implies that 





Table 4.2. Levene's test for homogeneity of variance for Total Cost 
Levene's Test for Homogeneity of Total_Cost Variance 
ANOVA of Squared Deviations from Group Means 
Source DF Sum of Squares Mean Square F Value Pr > F 
Gender*CM 3 2.54E11 8.467E10 9.80 <.0001 










Figure 4.2. Boxplots for the distribution of Total Cost for gender and CM levels 
We noted the skewness of our data, which is actually a feature worth exploring on its 
own, but continued nonetheless without removing the outliers performing a T-test to compare 
the cost between the two sets of interest. The first set contains the patients who are enrolled in 
that case management program (designation 1) for at least a year, and the second those who are 
not (designation 0). 
Our T-test hypothesis was formed based on our research question, thus our null and alternative 
hypothesis are: 
H0: Patients enrolled in CM or not, have the same average total cost 
H1: Patients enrolled in CM have different average total cost 
Based on the two-sided T-test results displayed in Table 4.3, the computed p value is much 
smaller than 0.05, therefore, the null hypothesis that patients enrolled and patients not enrolled 
have the same total cost is rejected.  By further inspecting the mean total cost for enrolled and 
not enrolled, we discover that patients enrolled in case management have a higher total cost on 
average. This may indicate, that since their cost was high, they were either asked to enroll or 
were self-enrolled in case management. However, this also raises a question about the 
effectiveness of the CM program at the insurance company where this study takes place, and 
prompted us to further investigate how the cost changes overtime for patients who are case 




Table 4.3. T-test comparison between opting in or out from CM for total cost variable 
CM Method Mean 95% CL Mean Std Dev 95% CL Std Dev 
0 Not Enrolled 232.1 227.4 236.7 217.1 213.9 220.5 
1 Enrolled 285.4 255.7 315.2 240.9 221.7 263.9 
Diff (1-2) Pooled -53.3 -80.4 -26.1 217.9 214.7 221.2 
Diff (1-2) Satterthwaite -53.3 -83.4 -23.2    
 
 
Method Variances DF t Value Pr > |t| 
Pooled Equal 8621 -3.85 0.0001 
Satterthwaite Unequal 266.7 -3.49 0.0006 
Cochran Unequal . -3.49 0.0006 
 
 
Equality of Variances 
Method Num DF Den DF F Value Pr > F 
Folded F 254 8367 1.23 0.0158 
 
 
Figure 4.3. Displays side by side boxplots for the two groups, patients enrolled in CM and 
patients not enrolled in CM. The range and the mean of Total Cost is higher for patients enrolled. 
The same figure shows the distribution of Total Cost variable for both groups, the top graph 
presents the patients not enrolled in case management and the bottom one those enrolled in it.  
 
Figure 4.3. Side by side boxplot and histograms for enrolled and non-enrolled patients 
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4.2 Exploring the effect of case management on cost over time 
To further investigate how enrollment in case management changes the total cost over 
time and to compare that to the total cost over time for patients who have never been enrolled 
in case management, two random samples were selected from the study population. Each 
sample has 60 patients with their total cost in 2015 and total cost in 2017; 30 patients have been 
enrolled in case management in 2016 and 30 patients have never been enrolled in case 
management.   
The relative difference in total cost between 2017 and 2015 was found for the two samples 
of patients and a T-test procedure was performed to identify if there is a statistically significant 
difference in how the total cost changes over time based on patient’s enrollment in CM. The 
following equation was used to find the relative difference in total cost: 
𝑇𝑜𝑡𝑎𝑙 𝐶𝑜𝑠𝑡 2015 − 𝑇𝑜𝑡𝑎𝑙 𝐶𝑜𝑠𝑡 2017
𝑇𝑜𝑡𝑎𝑙 𝐶𝑜𝑠𝑡 2015
 
And the following hypothesis was tested: 
H0: The average relative difference between the cost in 2015 and 2017 is the same for the two 
groups 
H1: The average relative difference between the cost in 2015 and 2017 is not the same for the 
two groups 
Table 4.4 presents the T-test results for sample 1, since p is quite high we fail to reject the null 
hypothesis and thus there is no indication that there is a difference in the average relative 
difference cost changes between the two groups (CM vs NonCM). 




Table 4.5 displays estimates for the mean of the relative difference between the two years of the 
two groups. We observe that in our sample the average relative difference of the non-case 
managed group is approximately -0.91 which implies an increase in the cost between 2015 and 
2017.  
Similarly, the average relative difference of the case managed group is approximately -2.6 which 





Table 4.5. Sample 1: Estimates for average relative difference in the two groups 
Mean of difference in cost for non-case 
managed patients 




Similarly, for the second sample with another set of patients, we get the T-test results displayed 
in Table 4.6, and thus we once again fail to reject the null hypothesis.   




In other words, we have another indicator that suggests that there is no real change in enrolling 
in the case management service. 
 
For this result, Table 4.7 displays the estimates for the mean of the relative difference between 
the two years of the two groups.  
the average relative difference of the non-case managed group is approximately -3.05 which 
implies an increase in the cost between 2015 and 2017.  
Similarly, the average relative difference of the case managed group is approximately -0.31 
which again implies an increase in the cost between 2015 and 2017 and, in this case, it is higher 
than the non-case managed group.  
Table 4.7. Sample 2: Estimates for average relative difference in the two groups 
Mean of difference in cost for non-case 
managed patients 




The analysis above indicates that on random samples in our dataset, the relative difference in 
cost is not immediately related to being case managed or not. Further analysis is needed on 
bigger samples and it will definitely be a priority in future work. 
4.3 Forward variable selection procedure for total cost 
Next, a forward variable selection procedure was used to identify variables that are 
statistically significant in a regression model with total cost as the dependent variable. Prior to 
that, we performed a multicollinearity detection test. Table 4.8 displays the result of 
multicollinearity diagenetic using Variance Inflation Factor (VIF). The variables that have VIF value 
above 5 have multicollinearity. Number of ER claims and ER billed amount, Rx prescription drugs, 
billed amount and Rx paid Amisys which is the amount covered by the insurance company, as 
well as urgent care clinics billed amount and paid Amisys amount all have multicollinearity. 
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Table 4.8. Multicollinearity diagnostic for regression input variables 
Parameter Estimates 




t Value Pr > |t| Tolerance Variance 
Inflation 
CM 1 2.34026E-11 0 Infty <.0001 . 0 
Age 1 -1.8239E-14 0 -Infty <.0001 0.85469 1.17001 
Gender 1 -1.099E-13 0 -Infty <.0001 0.91969 1.08732 
DurationCM 1 -4.5348E-14 0 -Infty <.0001 0.95358 1.04868 
Income 1 -5.4341E-16 0 -Infty <.0001 0.97431 1.02637 
ER 1 -1.1549E-12 0 -Infty <.0001 0.12380 8.07760 
ER_Billed 1 1.00000 0 Infty <.0001 0.17238 5.80120 
ER_Amisys 1 -7.8251E-15 0 -Infty <.0001 0.27119 3.68743 
Primary 1 -5.9853E-13 0 -Infty <.0001 0.41128 2.43144 
Primary_Billed 1 1.00000 0 Infty <.0001 0.24491 4.08312 
Primary_Amisys 1 1.78235E-14 0 Infty <.0001 0.27364 3.65442 
Rx 1 -3.1673E-14 0 -Infty <.0001 0.24282 4.11827 
Rx_Billed 1 1.00000 0 Infty <.0001 0.06512 15.35568 
Rx_Amisys 1 3.81108E-14 0 Infty <.0001 0.07586 13.18139 
Urgent 1 2.75532E-12 0 Infty <.0001 0.58456 1.71069 
Urgent_Billed 1 1.00000 0 Infty <.0001 0.18243 5.48169 
Urgent_Amisys 1 1.92995E-14 0 Infty <.0001 0.21539 4.64265 
 
The input variables for the forward variable selection are: Age, gender, enrollment in case 
management program, duration in enrollment in case management program, number of claims 
for hospital stays and length of stay, number of emergency department claims, number of asthma 
medication claims, number of primary care office visits, number of urgent care clinics claims, 
number of ICU admission claims, length of stay and the billed amount for each claim. 
The analysis was carried over using the procedure PROC REG in SAS and the results are displayed 
in Table 4.9  
Table 4.9. Summary of forward variable selection 










C(p) F Value Pr > F 
1 Primary_Billed 1 0.55 0.55 . 319.0 <.0001 
2 ER_Billed 2 0.24 0.80 . 325.1 <.0001 
3 Rx_Billed 3 0.19 0.99 . 18452.9 <.0001 





The significant input variables according to our table are:  
a) claims for primary physician office visits,  
b) claims of emergency room visits,  
c) claims of pharmacy prescriptions and  
d) claims of urgent clinic visits. 
The regression equation is 
Total cost = a ∗ Primary +  a ∗ ER +  a ∗ Rx +  a ∗ Urgent + b   
This conforms to our intuition since all these variables come with a cost attached to them.  Other 
input variables such as gender and age do not have a statistically significant effect on total cost. 
The effect of gender on total cost was explored by performing a T-test between the two groups 
using designation 0 for male and designation 1 for females. The following hypothesis was tested: 
H0: Male and female patients, have the same average total cost 
H1: Male and female patients, have different average total cost 
Table 4.10 displays the T-test results. The p-value is lower than 0.05, therefore, we reject the null 
hypothesis. There is a clear difference between the average total cost with respect to the two 
genders in this dataset. On average male participants have a higher average total cost than that 
of females and their difference is statistically significant. 
This result need be explored further, in an experiment where all over variables are controlled and 
the only difference between the two groups analyzed is the gender. 
Figure 4.4 shows that the mean for male and female patients, where the mean for males is higher, 












Table 4.10. T-test for difference in Total Cost based on Gender 
Gender Method Mean 95% CL Mean Std Dev 95% CL Std Dev 
0 Male 248.6 242.5 254.8 228.4 224.1 232.8 
1 Female 231.1 224.9 237.2 213.9 209.7 218.4 
Diff (1-2) Pooled 17.5 8.84 26.2 221.7 218.7 224.9 
Diff (1-2) Satterthwaite 17.5 8.88 26.2    
 
 
Method Variances DF t Value Pr > |t| 
Pooled Equal 9975 3.95 <.0001 
Satterthwaite Unequal 9926.1 3.97 <.0001 
Cochran Unequal . 3.97 0.0001 
 
 
Equality of Variances 
Method Num DF Den DF F Value Pr > F 









4.4 Identifying factors associated with frequent use of health services 
Proc GLM was used to identify which factors are associated with frequent use of primary 
health services.    
The input variables are: Age, gender, income, and enrollment in case management program. 
The output variables are: Number of claims for the primary health services (emergency room 
visits, primary care physician office visit, prescriptions, ICU visits and urgent clinic visits). 
For the dependent variable ER (emergency room visits), the model is significant as the p-value is 
<0.0001 which is below 0.05 level of significance as displayed in Table 4.11.  
Table 4.11. Regression model: Dependent variable ER vs. input variables 
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 13 4.56 0.351 5.48 <.0001 
Error 9963 637.51 0.064   
Corrected Total 9976 642.07    
 
 
Source DF Type III SS Mean Square F Value Pr > F 
CM 1 0.841 0.841 13.15 0.0003 
Gender 1 0.171 0.171 2.68 0.1017 
Age 1 0.099 0.099 1.56 0.2115 
Income 1 1.020 1.020 15.95 <.0001 
CM*Gender 1 0.117 0.117 1.84 0.1752 
Age*CM 1 0.070 0.070 1.10 0.2938 
Income*CM 1 0.571 0.571 8.92 0.0028 
Age*Gender 1 0.110 0.110 1.72 0.1894 
Income*Gender 1 0.047 0.047 0.73 0.3926 
Age*Income 1 0.035 0.035 0.55 0.4592 
Age*Income*CM*Gender 3 0.151 0.051 0.79 0.4998 
 
 
Age and gender are not statistically significant in predicting the number of ER claims. The median 
income and enrollment in case management and their interaction are statistically significant. 
For the variable primary (number of claims for doctor’s office visits), the result is displayed in 
Table 4.12 . The regression model is significant with a p-value of <.0001 which is lower than the 





Table 4.12. Regression model: Dependent variable primary vs. input variables 
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 13 152.26 11.71 4.00 <.0001 
Error 9963 29185.38 2.93   
Corrected Total 9976 29337.65    
 
 
Source DF Type III SS Mean Square F Value Pr > F 
CM 1 0.34455308 0.34455308 0.12 0.7316 
Gender 1 0.77082514 0.77082514 0.26 0.6080 
Age 1 0.00272967 0.00272967 0.00 0.9756 
Income 1 0.53173249 0.53173249 0.18 0.6701 
CM*Gender 1 0.32913689 0.32913689 0.11 0.7375 
Age*CM 1 0.45600553 0.45600553 0.16 0.6932 
Income*CM 1 4.40326359 4.40326359 1.50 0.2202 
Age*Gender 1 1.46682070 1.46682070 0.50 0.4792 
Income*Gender 1 1.39829186 1.39829186 0.48 0.4896 
Age*Income 1 0.18635540 0.18635540 0.06 0.8009 
Age*Income*CM*Gender 3 3.84045050 1.28015017 0.44 0.7265 
 
 
All input variables and their interactions are not statistically significant to physician office visits. 
For the variable Rx, which is the number of pharmacy prescription claims, the results are 
displayed in Table 4.13. The model is significant with a p-value <.0001. 
Table 4.13. Regression model: Dependent variable Rx vs. input variables 
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 13 1052.53 80.963 5.16 <.0001 
Error 9963 156284.44 15.686   
Corrected Total 9976 157336.96    
 
 
Source DF Type III SS Mean Square F Value Pr > F 
CM 1 17.3910967 17.3910967 1.11 0.2924 
Gender 1 3.1446016 3.1446016 0.20 0.6544 
Age 1 39.1684699 39.1684699 2.50 0.1141 
Income 1 65.6563137 65.6563137 4.19 0.0408 
CM*Gender 1 81.2390475 81.2390475 5.18 0.0229 
Age*CM 1 28.2443578 28.2443578 1.80 0.1797 
Income*CM 1 1.3040926 1.3040926 0.08 0.7731 
Age*Gender 1 2.1682819 2.1682819 0.14 0.7101 
Income*Gender 1 0.8473760 0.8473760 0.05 0.8162 
Age*Income 1 39.6876279 39.6876279 2.53 0.1117 




The input variables enrollment in CM, Gender and age are not statistically significant with 
a p-value higher than 0.05 level of significance. Income was significant at 0.05 significance level 
well as the interaction between CM and gender and the interaction between age, income, CM 
and gender. 
For the ICU variable, number of ICU stays claims, the clean dataset had no ICU claims, so 
no results to be displayed for this variable. 
Also, the selected study population didn’t have admission claims, there was no result for 
the dependent variable hospital admission. 
For the urgent care clinics visits, the variable urgent vs other input variables model is 
displayed in Table 4.14. The model is significant with a low p-value that is <.0001. 
Table 4.14. Regression model: Dependent variable urgent vs. input variables 
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 13 0.618 0.047 3.17 <.0001 
Error 9963 149.318 0.015   
Corrected Total 9976 149.94    
 
 
Source DF Type III SS Mean Square F Value Pr > F 
CM 1 0.024 0.02451335 1.64 0.2010 
Gender 1 0.001 0.00057399 0.04 0.8448 
Age 1 0.018 0.01804803 1.20 0.2725 
Income 1 0.105 0.10484039 7.00 0.0082 
CM*Gender 1 0.037 0.03707976 2.47 0.1158 
Age*CM 1 0.003 0.00283862 0.19 0.6634 
Income*CM 1 0.032 0.03234035 2.16 0.1419 
Age*Gender 1 0.004 0.00369444 0.25 0.6196 
Income*Gender 1 0.0001 0.00005297 0.00 0.9526 
Age*Income 1 0.025 0.02460324 1.64 0.2001 




Age, gender, enrollment in case management were not significant in the regression model 
as well as the interaction of all the variables. However, Income was the only significant input 
variable with a p-value of 0.0082 which is less than the 0.05 level of significance. This means that 
median income has a statistically significant effect on the number of urgent clinics claims. To 
further investigate how income affects the urgent clinics claims, chi-square tables were 
generated. First, the population was classified into four classes based on the four quartiles of 
population median income in the dataset, and the following hypothesis was tested: 
H0: Median income and number of urgent clinics visits are independent 
H1: Median income and number of urgent clinics visits are not independent 
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The p-value for median income vs number of urgent clinics visit is 1.51E-10 which is lower than 
0.05 level of significance, so we reject the null hypothesis.  
Table 4.15 displays the chi-square expected vs. actual values. The bolded values in the first row 
show the actual values of urgent clinics claims in the data and the second row show the expected 
values for each quartile. 
Table 4.15. Chi Square results: How income is affecting the number of urgent clinics claims, 
actual values vs expected values 






















Theoretically people with high income are expected to make approximately 21 visits to the urgent 
care clinics, however, the actual data shows that patients with high income had 49 urgent clinic 
claims; this means that patients in our dataset with high income tend to utilize urgent care clinics 
more than expected. On the other hand, patients with lowest income quartile had only 9 urgent 
care clinics claims, this indicates that patients with lowest income level, tend to utilize urgent 
care clinics less than expected.  
The chi-square result shows that there is a difference in the preference in visiting the urgent 
care clinic based on income level and patients with higher income are more likely to utilize urgent 
care clinics based on the presented chi-square tables. 
4.5 Neural networks (NN) vs linear regression in prediction of total cost 
As a side result we built a predicting model for the total cost, based on the other input 
variables using machine learning tools and specifically an Artificial Neural Network. The R 
statistical software was used to create the Neural Network and we compared its accuracy against 
a simple Linear Regression predictor.  
Generally, it is expected that a larger number of layers and nodes in a Neural Network 
increases the prediction accuracy but at the cost of computational speed and memory resources. 
For this study and in an effort to maintain a balance between efficiency and accuracy, we chose 
an architecture of two hidden layers with 7 and 6 nodes each. The architecture was informed by 
an initial analysis of possible architectures on smaller datasets of 1000 points, where various 
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configurations were tried. Although 7, 6 was not always the best in terms of prediction, it always 
scored among the top 5 models.  
In order to have a robust analysis of our predictive method, we repeated the process, 40, 
times using initially subsets of 5,000 data points. 
The training set had 4,500 (90%) points and then it was tested on the remaining 500 points 
(10%). The neural network prediction was compared to that of a multilinear regression model on 
the same learning and test sets. The l_2 norm (distance) between the predicted value and the 
real value was used as an indicator of better prediction, for each of the subsets.  
The average distance between predicted value by NN and true value is 1.3619 and the 
average distance between linear model predicted value and true value is 1.1803. Out of the 40 
repetitions we tried, the NN outperformed Linear Regression 15 times. This implies that when 
using 5,000 datapoints, for the most part, the LR model is outperforming the NN model in 
predicting the total cost. 
The same process was repeated for datasets of 6,000 data points. Again, we compared the 
accuracy of the two models in 40 repetitions. This time, the NN outperformed the linear 
regression 32 times out of 40. So, with 6,000 data points, the NN starts outperforming the 
regression model.  
Finally, the process was repeated for subsets of 8,000 data points, again for 40 repetitions. 
This time the NN outperformed the regression model 35 times. The average distance of the 
predictions of the neural network from the true value were 1.033 and that of the linear model 
1.317.   
This implies that our NN outperforms the linear model in the prediction of the total cost 
based on all the other input variables as the number of data points increase. The proposed 
threshold point based on this dataset is somewhere close to 6,000 points. It is expected that NN’s 
will continue to outperform linear regression as the number of data points increases. The 
predictive model we have created can now be used to predict the Total Cost an individual will be 
facing based on their characteristics, with a high enough accuracy. Figure 4.5 is a visual 
representation of one of the networks we created.  
Given a patients’ demographics (age and gender) and socio-economic indicator (zip code 
or median income) along with patient’s history in utilizing health services in terms of number of 
claims and billed amount of each claim, the NN model can attempt to predict the future total 
cost of the patient. This prediction can be then used to decide whether this patient should be 
enrolled in case management or not. Alternatively, a linear regression model can be used with 
similar input and output. The question on which model to use lies in the size the available dataset. 
For a small number of data points, a linear model will yield more accurate prediction but for 









 Discussion and Limitations 
First of all, we need to make it clear that the results of this study are applied to the provided 
dataset, and although the give us good indicators of the general population’s behavior we do not 
claim that our results are immediately generalizable.  
This study found that asthma patients total cost is primarily driven by the billed amount for 
the following claims: primary physician office visits, emergency room visits, pharmacy 
prescriptions and urgent care clinic visits. Furthermore, the data analysis showed that there is a 
difference in total cost with respect to gender, and male patients have a higher asthma related 
cost compared to female patients. Since the majority of our study population is underaged 
children, this finding is consistent with another study that reported that younger male patients 
who are Medicaid insured have higher ER visits, which translates to cost (Nath & Hsia, 2015). 
With respect to factors associated with frequent utilization of primary health services, we 
found that patient income and enrollment in case management were the significant factors in 
predicting the number of emergency room visits. Similar studies that looked at the effect of 
gender and age on emergency room visits, reported that emergency room visits were influenced 
by age, where younger patients had more visits and it decreased with age (Baibergenova et al., 
2005).  
For urgent care clinics visits, patient’s median income was a significant factor, patients who 
had higher income were more likely to utilize urgent care clinics. A previous study related socio-
economic factor to another health resource utilization, and the study found that lower income is 
associated with higher risk of hospitalization (Eisner et al., 2001). 
The comparison in total cost between patients enrolled in case management vs patients not 
enrolled showed that there was no real change over time in the mean of difference in cost upon 
enrollment in case management. This could indicate that asthma patients who were enrolled in 
case management do require to be case managed as they do have a higher overall cost. However, 
it also raises a question about the degree of effectiveness of the current approach of case 
management. This study proposed common success factors for case management as collected 
from literature.  
For the total cost prediction model, the linear regression outperformed NN in predicting total 
cost for the 5,000 datapoints run, however, the NN stated outperforming linear regression as the 
number of datapoints increased, this study proposes the threshold of datapoints needed to train 
NNs to outperform a linear regression model in prediction at around 6,000 points. It is also 
expected that the larger number of data points, the better the NN will perform compared to 
linear regression. 
There were several limitations of this study, first, patient factors such as marital status, race 
and ethnicity weren’t captured in the claims data. Secondly, patients asthma severity level was 
not indicated in the data which limited our ability to examine the effect of asthma severity on 
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cost. Third, our dataset was only for Medicaid insured patients in Louisiana, which limits the 
external validity of this study findings, our findings cannot be generalized and applied to other 
types of insurance such as private insured patients. And lastly, the study duration is limited, as 




This study conducted an analysis of Medicaid insured patients in Louisiana. It was found that 
patients with history of claims related to emergency room visits, pharmacy prescription, urgent 
care clinic visits and primary physician claims have a higher overall cost. The case management 
enrollment has no significant effect on the total cost over time for patients who are case 
managed compared to those that are not. Median income was significant in predicting the 
number of emergency room, urgent care clinics and pharmacy prescription claims. And finally, as 
side result, this study built two prediction models for total cost, for low number of data points, 
linear regression model was able to predict total cost with a good enough accuracy and the 
threshold number of points in which the neural network outperforms linear regression is about 
6,000 point, so for higher number of data points, neural networks was a better prediction  model, 
and the accuracy of neural network prediction is expected to increase as the number of data 
points increases.  
This study is a foundation for further future analysis of asthma patients demographics, claims 
history and their association with health resources utilization. Excessive health resources 
utilization is an indication of poor disease management and places a burden on the economy and 
society. Future work is to collect patients information and diversify the source of data to include 
multiple insurance types from different geographical regions and patients from all age groups. 
Furthermore, future analysis should be conducted over longer period of time to better examine 
the effectiveness of case management in reducing overall cost. Finally, future studies can also 
look at other demographic and clinical factors that weren’t captured in this study such as race, 
education level, marital status and asthma severity level to examine their effect on asthma 
overall cost and level of utilization of primary health services. 
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